Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients

Table 1 Treatment outcomes n (%)

Hepatitis C virus genotype	Virologic response				Resistant	Breakthrough	Relapse
	Rapid	Early	End of treatment	Sustained
Type-11 (n = 94)	42 (44.7)	86 (91.5)	85 (90.4)	77 (81.9)	6 (6.4)	3 (3.2)	8 (8.5)
Type-3 (n = 56)	47 (83.9)b	49 (89.1)2	56 (100)	51 (91.1)	0 (0)	0 (0)	5 (8.9)
Mixed type-1 and -3 (n = 2)	1 (50.0)	2 (100)	2 (100)	2 (100)	0 (0)	0 (0)	0 (0)
Total (n = 152)	90 (59.2)	137 (90.7)2	143 (94.1)	130 (85.5)	6 (3.9)	3 (2.0)	13 (8.6)

¹Includes one patient with mixed hepatitis C virus genotype-1a/4;

²Data from one patient was missed;

^bP < 0.01 vs type-1.